ArticleNature communications2025

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study.

Zihao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.